Advanced Cancer and Survivorship

Advanced cancer generally means cancer that is difficult to cure or has spread, although the exact meaning varies by cancer type. Metastatic cancer has spread from its original site to another part of the body. It is named after the original cancer; for example, breast cancer in bone remains metastatic breast cancer.

No. Many advanced cancers can be controlled for months or years, and some selected metastatic cancers may have long remissions or occasionally be treated with curative intent. Goals may include shrinking cancer, delaying progression, relieving symptoms and maintaining quality of life. The likely benefit differs greatly between diseases and individuals.

The team considers cancer type and biology, previous treatment, extent of disease, symptoms, organ function, performance status, expected benefit, side effects and the patient's priorities. The goal should be stated clearly as cure, long-term control, life prolongation, symptom relief or a combination. Goals can change over time.

Performance status describes how well a patient can carry out daily activities and self-care. It helps estimate whether a treatment is likely to be tolerated and whether benefits may outweigh harms. A low score may improve if a reversible problem such as infection, pain or fluid accumulation is treated. It should not be judged from age alone.

You may ask, "What is the best case, worst case and most likely situation?" or "Are we thinking in weeks, months or years?" Prognosis is an estimate, not an exact date, and depends on response and complications. Tell the doctor how much detail you want and whether you want family present.

Survival statistics describe groups and cannot predict an individual precisely. Cancer biology, treatment response, general health and unexpected complications all matter. Doctors can often provide a range and explain signs that the situation is changing. Estimates should be updated when new information becomes available.

The team confirms progression and reviews whether another standard treatment, a clinical trial, a local procedure or symptom-focused care may help. A new treatment is not automatically better; likely benefit, toxicity, cost, travel and time in hospital should be considered. Supportive care continues regardless of the decision.

No. Declining a treatment with little expected benefit or excessive burden can be a reasoned medical decision. Care continues through symptom control, nursing, psychological support and family support. The plan should reflect informed patient preferences, not pressure from others.

Sometimes. A break may allow recovery, clarify whether symptoms are treatment-related or provide time for an important event. In other situations, delay may reduce the chance of benefit. Ask what might happen during the break, what monitoring is needed and what would trigger restarting or changing treatment.

It is a structured conversation about what matters most to the patient, the medical situation, realistic treatment options and preferences if health worsens. It may include hospitalisation, ICU care, resuscitation and preferred place of care. The discussion is not a single event and should be revisited as circumstances change.

The patient's informed preferences have priority when the patient has decision-making capacity. A joint meeting with the oncology or palliative-care team can clarify facts, goals and misunderstandings. Social workers, counsellors, ethics services or spiritual advisers may help. Family members should not be asked to make decisions without adequate information and support.

Patients may choose how much information they want. The clinician can ask permission to discuss details and identify a trusted person to receive information, while still obtaining necessary consent. Preferences may change over time. Avoid forcing information, but ensure that decisions are informed enough to be safe and lawful.

The term is often used from diagnosis onward, although not everyone identifies with it. Some prefer "person living with cancer" or simply "patient." The label is personal and does not determine eligibility for follow-up care. People on long-term treatment also have survivorship needs.

It summarises the diagnosis, stage, pathology, important biomarkers, surgery, medicines, radiotherapy and major complications. It also lists follow-up visits, tests, possible late effects, health-promotion advice and who is responsible for each part of care. Keep it with your medical records and share it with other doctors.

Frequency depends on cancer type, stage, treatment, time since treatment and symptoms. Visits may be closer together initially and less frequent later. Follow-up should also include general health care, not only recurrence surveillance. Keep appointments even when feeling well.

No. Evidence-based surveillance differs by cancer. Some cancers need scheduled imaging; others rely mainly on history, examination and selected tests. Excess scanning can cause radiation exposure, false alarms, anxiety and unnecessary procedures. New concerning symptoms should be assessed even between planned scans.

They are useful in selected cancers and situations but are not universal screening tests. A rising value may have non-cancer causes and usually needs confirmation and clinical correlation. A normal marker does not exclude recurrence. Do not order broad marker panels without a clear indication.

Report a persistent new lump, unexplained weight loss, unusual bleeding, progressive pain, breathlessness, neurological symptoms, persistent change in bowel or bladder habits, or symptoms specific to the original cancer. Most symptoms are not recurrence, but persistent or worsening symptoms deserve assessment. Emergency red flags should not wait for a clinic appointment.

Recurrence is return of the original cancer locally, regionally or at a distant site. A second primary is a new, biologically separate cancer. Pathology, imaging and molecular tests may help distinguish them. The treatment and prognosis can differ substantially.

Yes, although risk varies widely by cancer type and biology. Some cancers recur mostly in the first few years, while others can recur later. Follow the recommended long-term plan and report persistent symptoms. Fear alone should not lead to indefinite unplanned scans.

Possible late effects include heart or lung problems, neuropathy, bone loss, hormonal dysfunction, infertility, lymphoedema, cognitive changes, dental problems and second cancers. Risk depends on treatment and dose. A survivorship plan should identify which effects are relevant and what monitoring is appropriate.

Yes. Survivors still need age- and risk-appropriate screening such as cervical, breast or colorectal screening unless individual circumstances change it. Some treatments or genetic risks require earlier or additional screening. Coordinate cancer-specific follow-up with primary care.

New swelling, heaviness, tightness, reduced movement or recurrent skin infection in an at-risk limb or area should be reported. Early assessment, skin care, exercise, compression when prescribed and specialist therapy may help. Sudden painful swelling also requires evaluation for infection or a blood clot.

Regular individualised activity supports cardiovascular health, strength, mood, sleep and function. Start gradually and account for surgery, neuropathy, cardiopulmonary disease, lymphoedema and bone metastases. A physiotherapist or rehabilitation specialist can create a safe plan. New chest pain, fainting or severe breathlessness requires assessment.

Recovery is affected by treatment intensity, age, other illnesses, nutrition, sleep, pain, emotional distress and loss of fitness. Friends and employers may expect a rapid return to normal even when fatigue and cognitive changes persist. Set gradual goals and investigate symptoms that are worsening rather than slowly improving.

Know the surveillance plan, warning symptoms and contact route. Limit repeated self-examination and unstructured internet searching, especially before scans. Counselling, cognitive behavioural approaches, mindfulness and peer support may help. Persistent fear that disrupts sleep, work or relationships deserves professional support.